Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dezocine pretreatment for prevention of etomidate-induced myoclonus
ChiCTR-TRC-13004080Phase 4Completed
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Nov 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dezocine and etomidate (2 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: mean arterial pressure, heart rate and 2 more. Started Nov 2013; status: completed.
02
Drugs
dezocineetomidate
Beyond the preview
Go deeper on ChiCTR-TRC-13004080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13004080.